Source: Sprim Als Blog

Sprim Als Blog ObvioHealth Introduces ObvioGo 2.2: Transforming Study Management with AI-Driven Innovation

AI-Driven Enhancements in ObvioGo 2.2 Redefine Efficiency, Compliance, and Innovation in Clinical Trial Management NEW YORK, Jan. 14, 2025 /PRNewswire/ -- ObvioHealth, a global leader in digital clinical trial solutions, today announced the release of ObvioGo 2.2, the latest version of its innovative ... Read More The post ObvioHealth Introduces ObvioGo 2.2: Transforming Study Management with AI-Driven Innovation appeared first on SPRIM.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
250-500
Michael Shleifer's photo - Managing Partner of Sprim Als

Managing Partner

Michael Shleifer

CEO Approval Rating

72/100

Read more